Cargando…

Current management options for recurrent adrenocortical carcinoma

Adrenal cortical carcinoma (ACC) is a rare cancer that poses a number of management challenges due to the limited number of effective systemic treatments. Complete surgical resection offers the best chance of long-term survival. However, despite complete resection, ACC is associated with high recurr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glover, Anthony R, Ip, Julian C Y, Zhao, Jing Ting, Soon, Patsy S H, Robinson, Bruce G, Sidhu, Stan B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681406/ https://www.ncbi.nlm.nih.gov/pubmed/23776337 http://dx.doi.org/10.2147/OTT.S34956

Ejemplares similares

microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
por: Glover, Anthony R., et al.
Publicado: (2015)

Key MicroRNA’s and Their Targetome in Adrenocortical Cancer
por: Chehade, Marthe, et al.
Publicado: (2020)

Current and Emerging Therapeutic Options in Adrenocortical Cancer Treatment
por: Stigliano, Antonio, et al.
Publicado: (2012)

Surgical Management of Adrenocortical Carcinoma: Current Highlights
por: Cavallaro, Giuseppe, et al.
Publicado: (2021)

MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers
por: Zearo, Silvia, et al.
Publicado: (2014)

Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options
por: Al-Ward, Ruaa, et al.
Publicado: (2022)

Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012)

Adrenocortical Carcinoma
por: Berruti, Alfredo, et al.
Publicado: (2021)

Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging Options
por: Hescheler, Daniel Alexander, et al.
Publicado: (2022)

Management of adrenocortical carcinoma: are we making progress?
por: Kiesewetter, Barbara, et al.
Publicado: (2021)

Massive Biochemically Silent Pheochromocytoma Masquerading as Nonfunctioning Adrenocortical Cancer
por: Kumar, Shejil, et al.
Publicado: (2023)

Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane
por: Alam, Walid, et al.
Publicado: (2021)

Mitotane in adrenocortical carcinoma.
por: Vassilopoulou-Sellin, R., et al.
Publicado: (1994)

Pediatric adrenocortical carcinoma
por: Ilanchezhian, Maran, et al.
Publicado: (2022)

Surgical Management of Adrenocortical Carcinoma: A Literature Review
por: Rossi, Leonardo, et al.
Publicado: (2022)

Recurrent Intussusception: Management Options
por: Mirza, Bilal
Publicado: (2011)

Adrenocortical oncocytic carcinoma with recurrent metastases: a case report and review of the literature
por: Argyriou, Pinelopi, et al.
Publicado: (2008)

SUN-388 Immune Checkpoint Inhibitor Nivolumab in Advanced or Recurrent Adrenocortical Carcinoma
por: Akunjee, Munaza, et al.
Publicado: (2019)

Recurrent Amplification of the Osmotic Stress Transcription Factor NFAT5 in Adrenocortical Carcinoma
por: Brown, Taylor C, et al.
Publicado: (2020)

Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma
por: Chortis, Vasileios, et al.
Publicado: (2019)

Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
por: Puglisi, Soraya, et al.
Publicado: (2019)

Current treatment options for recurrent nasopharyngeal cancer
por: Suárez, Carlos, et al.
Publicado: (2010)

The Potential of Steroid Profiling by Mass Spectrometry in the Management of Adrenocortical Carcinoma
por: Rossi, Claudia, et al.
Publicado: (2020)

Molecular Markers Guiding Thyroid Cancer Management
por: Nylén, Carolina, et al.
Publicado: (2020)

Adrenocortical Carcinoma and Synchronous Malignancies
por: Guerrero, Marlon A., et al.
Publicado: (2010)

Apoptosis regulation in adrenocortical carcinoma
por: Pereira, Sofia S, et al.
Publicado: (2019)

Estrogen-secreting adrenocortical carcinoma
por: Jeong, You, et al.
Publicado: (2018)

Non-functioning adrenocortical carcinoma
por: Lenh, Bui-Van, et al.
Publicado: (2021)

Medical Approaches in Adrenocortical Carcinoma
por: Paragliola, Rosa Maria, et al.
Publicado: (2020)

The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives
por: Mizdrak, Maja, et al.
Publicado: (2021)

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas
por: Bullock, Martyn, et al.
Publicado: (2016)

Adrenocortical Carcinoma in an Adult: Eight Months without Recurrence after Resection and Adjuvant Chemotherapy
por: Siosaki, Marcos Duarte, et al.
Publicado: (2014)

Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study
por: Tiberio, Guido Alberto Massimo, et al.
Publicado: (2020)

Recurrent Cushing Syndrome From Metastatic Adrenocortical Carcinoma With Fumarate Hydratase Allelic Variant
por: Silverman, Emily, et al.
Publicado: (2022)

Rare complication of acute adrenocortical dysfunction in adrenocortical carcinoma after transcatheter arterial chemoembolization: A case report
por: Wang, Zhi-Long, et al.
Publicado: (2021)

Cushing Syndrome due to Adrenocortical Carcinoma During Pregnancy
por: Morris, Jack Andrew, et al.
Publicado: (2023)

Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020
por: Tombetti, Enrico, et al.
Publicado: (2020)

Recurrent Differentiated Thyroid Cancer: The Current Treatment Options
por: Coca-Pelaz, Andrés, et al.
Publicado: (2023)

Recurrent Hypokalemia as an Unusual Presentation for Metastatic Adrenocortical Cancer
por: Mirza, Naomi, et al.
Publicado: (2022)

Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t7m1g3dsqfecr2udo47278788r